Restructuring of erythropoiesis and immune status in hypotrophic calves with comorbid pathologies based on the use of aminoseleferon-B

The article presents the results of comparative therapeutic efficacy of a complex biogenic drug aminoseleferon-B based on recombinant interferons on Holstein calves with hypotrophy and comorbid pathology (anemia, immunodeficiency) in the neonatal period. According to the principle of pairanalogues, four groups of 6 individuals (hypotopic calves with comorbid pathology) were formed and the fifth – 6 normotrophic calves. The calves of the first experimental group were administered aminoseleton, the calves of the second experimental group - biferon-B, the calves of the third experimental group - the drug aminoseleferon-B. The drugs were administered subcutaneously, three times on days 1, 3 and 30 at a dose of 1 ml per 10 kg of animal weight. The calves of the fourth experimental group - negative control and the calves of the fifth group - positive control, the studied drugs were not used. The use of aminoseleferon-B leads to an earlier stabilization (on day 7 of our studies) of the morphological and immunological blood composition, whereas in the comparison groups, the studied indicators were optimized on day 30. In the animals of the 3rd experimental group, the level of erythrocytes increased by 9.3% and 6.4% compared to those in hypotrophic calves, a similar pattern was noted in the amount of total hemoglobin - increased by 13.7% and 7.7%. Humoral and cellular links of nonspecific protection were restored in the calves of the 3rd experimental group, due to normalization of serum compliment, lysozyme and bacterial activity, phagocytic index and number. The use of aminoseleferon-B in the treatment of polymorbid pathology (anemia, immunodeficiency) in calves with hypotrophy has a pathogenetically mediated mechanism of action and a pronounced anti-anemic and immunomodulatory effect that together improves the state of the calves body during early neonatal adaptation.

1. Dronov V.V., Microelementoses of cows as a cause of hypotrophy in newborn calves 2017. - No. 3 (15). - P. 145-151 (in Russ.)

2. Kovalev S.P., Voinova A.A., Trushkin V.A., Effect of selenium-containing drugs on the clinical status of hypotrophic calves 2018. No. 1. - P. 101-103 (in Russ.)

3. Methodical recommendations for the assessment and correction of nonspecific resistance in animals. A.G. Shakhov, Yu.N. Brigadirov, A.I. Anufriev [et al.] - Voronezh: Istoki, 2005. - 62 p. (in Russ.)

4. Shakhov A.G., Fedosov D.V., Sashnina L.Yu. [et al.] Features of protective systems in calves with hypotrophy syndrome and their role in the development of neonatal pathology. 2013. - No. 2. - P. 27-30 (in Russ.)

5. Shabunin S.V., Alekhin Yu.N., Nezhdanov A.G., Perinatal pathology in cattle – an urgent problem of veterinary medicine 2015. - No. 1. - P. 3-10 (in Russ.)

6. Effect of the Preparation Based on Recombinant IFN-λ on the Immune Status of Hypotrophic Calves / S. Shabunin, P. Parshin, G. Vostroilova [et al.] // Fundamental and Applied Scientific Research in the Development of Agriculture in the Far East: Agricultural Innovation Systems, Volume 2, Ussuriysk, July 21–22, 202. Vol. 354. – Ussuriysk, 2022. – P. 303-312.

7. Hulbert LE, Moisa SJ. Stress, immunity, and the management of calves. J Dairy Sci. 2016;99(4):3199–216.

8. Osorio, JS Gut health, stress, and immunity in neonatal dairy calves: the host side of host-pathogen interactions / J.S. Osorio / / Journal of animal science and biotechnology. - 2020. - 11 (1). doi.org/10.1186/s40104-020-00509-3

9. Savrasov D.A. Сorrection of the immune status of cows by using Aminoseleton during the dry period for prevention of antenatal calf hypotrophy / D.A. Savrasov [et al.] // Journal of Animal Health and Production. - 2019. - V 7. – No. 3. - P. 99-105.

10. Validation of key indicators in cattle farms at high risk of animal welfare problems: A qualitative case-control study / P.C. Kelly, S.J. More, M. Blake, I. Higgins [et al.] / / Vet. Rec. - 2013. -V.172. - P. 314